Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report By Vaccine Type (Attenuated, Inactivated), By Workflow (Downstream, Upstream), By Application (Human, Veterinary), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                    1.5. Details of Primary Research
                        1.5.1. Data For Primary Interviews In North America
                        1.5.2. Data For Primary Interviews In Europe
                        1.5.3. Data For Primary Interviews In Asia Pacific
                        1.5.4. Data For Primary Interviews In Latin America
                        1.5.5. Data for Primary Interviews In MEA
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis (Model 1)
                            1.7.1.1. Approach 1: Commodity Flow Approach
                        1.7.2. Volume price analysis (Model 2)
                            1.7.2.1. Approach 2: Volume Price Analysis
                    1.8. Research Scope and Assumptions
                        1.8.1. List of Secondary Sources
                        1.8.2. List of Primary Sources
                        1.8.3. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Vaccine Contract Manufacturing Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Capacity Expansion By Contract Manufacturers For Vaccine Manufacturing
                            3.2.1.2. Global Increase in Vaccination Coverage
                            3.2.1.3. Vaccination Innovation and Robust Vaccine Pipeline
                            3.2.1.4. Cost and Time-Saving Benefits Offered By Contract Services
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Limited Outsourcing By Well-Established Vaccine Manufacturers
                    3.3. Vaccine Contract Manufacturing Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining Power of The Suppliers
                            3.3.1.2. Bargaining Power of The Buyers
                            3.3.1.3. Threats of Substitution
                            3.3.1.4. Threats From New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political Landscape
                            3.3.2.2. Economic and Social Landscape
                            3.3.2.3. Technological Landscape
Chapter 4. Vaccine Contract Manufacturing Market: Vaccine Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Vaccine Contract Manufacturing Market: Type Movement Analysis
                    4.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
                    4.4. Attenuated Vaccine
                        4.4.1. Attenuated Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Inactivated Vaccine
                        4.5.1. Inactivated Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Subunit Vaccines
                        4.6.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Toxoid Vaccines
                        4.7.1. Toxoid Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.8. DNA Vaccines
                        4.8.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Vaccine Contract Manufacturing Market: Workflow Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Vaccine Contract Manufacturing Market: Workflow Movement Analysis
                    5.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
                    5.4. Downstream
                        5.4.1. Downstream Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.2. Fill & Finish Operations
                            5.4.2.1. Fill & Finish Operations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.3. Analytical & QC Studies
                            5.4.3.1. Analytical & QC Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.4. Packaging
                            5.4.4.1. Packaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Upstream
                        5.5.1. Upstream Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.2. Mammalian Expression Systems
                            5.5.2.1. Mammalian Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.3. Bacterial Expression Systems
                            5.5.3.1. Bacterial Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.4. Yeast Expression Systems
                            5.5.4.1. Yeast Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.5. Baculovirus/Insect Expression Systems
                            5.5.5.1. Baculovirus/Insect Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.6. Others
                        5.5.7. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Vaccine Contract Manufacturing Market: Application Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Vaccine Contract Manufacturing Market: Application Movement Analysis, USD Million, 2022 & 2030
                    6.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    6.4. Human Use
                        6.4.1. Human Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Veterinary
                        6.5.1. Veterinary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Vaccine Contract Manufacturing Market: Regional Estimates & Trend Analysis, by Services, by Area, by Demographic
                    7.1. Vaccine Contract Manufacturing Market: Regional Movement Analysis, 2022 & 2030
                    7.2. North America
                        7.2.1. North America Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.2.2. U.S.
                            7.2.2.1. Key Country Dynamics
                            7.2.2.2. Competitive Scenario
                            7.2.2.3. Prevalence Insights
                            7.2.2.4. Regulatory Framework
                            7.2.2.5. Reimbursement Structure
                            7.2.2.6. U.S. Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.2.3. Canada
                            7.2.3.1. Key Country Dynamics
                            7.2.3.2. Competitive Scenario
                            7.2.3.3. Prevalence Insights
                            7.2.3.4. Regulatory Framework
                            7.2.3.5. Reimbursement Structure
                            7.2.3.6. Canada Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.3. Europe
                        7.3.1. Europe Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.2. UK
                            7.3.2.1. Key Country Dynamics
                            7.3.2.2. Competitive Scenario
                            7.3.2.3. Prevalence Insights
                            7.3.2.4. Regulatory Framework
                            7.3.2.5. Reimbursement Structure
                            7.3.2.6. UK Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.3. Germany
                            7.3.3.1. Key Country Dynamics
                            7.3.3.2. Competitive Scenario
                            7.3.3.3. Prevalence Insights
                            7.3.3.4. Regulatory Framework
                            7.3.3.5. Reimbursement Structure
                            7.3.3.6. Germany Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.4. France
                            7.3.4.1. Key Country Dynamics
                            7.3.4.2. Competitive Scenario
                            7.3.4.3. Prevalence Insights
                            7.3.4.4. Regulatory Framework
                            7.3.4.5. Reimbursement Structure
                            7.3.4.6. France Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.5. Italy
                            7.3.5.1. Key Country Dynamics
                            7.3.5.2. Competitive Scenario
                            7.3.5.3. Prevalence Insights
                            7.3.5.4. Regulatory Framework
                            7.3.5.5. Reimbursement Structure
                            7.3.5.6. Italy Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.6. Spain
                            7.3.6.1. Key Country Dynamics
                            7.3.6.2. Competitive Scenario
                            7.3.6.3. Prevalence Insights
                            7.3.6.4. Regulatory Framework
                            7.3.6.5. Reimbursement Structure
                            7.3.6.6. Spain Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.7. Denmark
                            7.3.7.1. Key Country Dynamics
                            7.3.7.2. Competitive Scenario
                            7.3.7.3. Prevalence Insights
                            7.3.7.4. Regulatory Framework
                            7.3.7.5. Reimbursement Structure
                            7.3.7.6. Denmark Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.8. Sweden
                            7.3.8.1. Key Country Dynamics
                            7.3.8.2. Competitive Scenario
                            7.3.8.3. Prevalence Insights
                            7.3.8.4. Regulatory Framework
                            7.3.8.5. Reimbursement Structure
                            7.3.8.6. Sweden Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.9. Norway
                            7.3.9.1. Key Country Dynamics
                            7.3.9.2. Competitive Scenario
                            7.3.9.3. Prevalence Insights
                            7.3.9.4. Regulatory Framework
                            7.3.9.5. Reimbursement Structure
                            7.3.9.6. Norway Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Asia Pacific
                        7.4.1. Asia Pacific Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.2. Japan
                            7.4.2.1. Key Country Dynamics
                            7.4.2.2. Competitive Scenario
                            7.4.2.3. Prevalence Insights
                            7.4.2.4. Regulatory Framework
                            7.4.2.5. Reimbursement Structure
                            7.4.2.6. Japan Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.3. China
                            7.4.3.1. Key Country Dynamics
                            7.4.3.2. Competitive Scenario
                            7.4.3.3. Prevalence Insights
                            7.4.3.4. Regulatory Framework
                            7.4.3.5. Reimbursement Structure
                            7.4.3.6. China Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.4. India
                            7.4.4.1. Key Country Dynamics
                            7.4.4.2. Competitive Scenario
                            7.4.4.3. Prevalence Insights
                            7.4.4.4. Regulatory Framework
                            7.4.4.5. Reimbursement Structure
                            7.4.4.6. India Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.5. Australia
                            7.4.5.1. Key Country Dynamics
                            7.4.5.2. Competitive Scenario
                            7.4.5.3. Prevalence Insights
                            7.4.5.4. Regulatory Framework
                            7.4.5.5. Reimbursement Structure
                            7.4.5.6. Australia Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.6. Thailand
                            7.4.6.1. Key Country Dynamics
                            7.4.6.2. Competitive Scenario
                            7.4.6.3. Prevalence Insights
                            7.4.6.4. Regulatory Framework
                            7.4.6.5. Reimbursement Structure
                            7.4.6.6. Thailand Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.7. South Korea
                            7.4.7.1. Key Country Dynamics
                            7.4.7.2. Competitive Scenario
                            7.4.7.3. Prevalence Insights
                            7.4.7.4. Regulatory Framework
                            7.4.7.5. Reimbursement Structure
                            7.4.7.6. South Korea Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Latin America
                        7.5.1. Latin America Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.2. Brazil
                            7.5.2.1. Key Country Dynamics
                            7.5.2.2. Competitive Scenario
                            7.5.2.3. Prevalence Insights
                            7.5.2.4. Regulatory Framework
                            7.5.2.5. Reimbursement Structure
                            7.5.2.6. Brazil Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.3. Mexico
                            7.5.3.1. Key Country Dynamics
                            7.5.3.2. Competitive Scenario
                            7.5.3.3. Prevalence Insights
                            7.5.3.4. Regulatory Framework
                            7.5.3.5. Reimbursement Structure
                            7.5.3.6. Mexico Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.4. Argentina
                            7.5.4.1. Key Country Dynamics
                            7.5.4.2. Competitive Scenario
                            7.5.4.3. Prevalence Insights
                            7.5.4.4. Regulatory Framework
                            7.5.4.5. Reimbursement Structure
                            7.5.4.6. Argentina Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.6. Middle East & Africa
                        7.6.1. Middle East & Africa Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.2. South Africa
                            7.6.2.1. Key Country Dynamics
                            7.6.2.2. Competitive Scenario
                            7.6.2.3. Prevalence Insights
                            7.6.2.4. Regulatory Framework
                            7.6.2.5. Reimbursement Structure
                            7.6.2.6. South Africa Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.3. Saudi Arabia
                            7.6.3.1. Key Country Dynamics
                            7.6.3.2. Competitive Scenario
                            7.6.3.3. Prevalence Insights
                            7.6.3.4. Regulatory Framework
                            7.6.3.5. Reimbursement Structure
                            7.6.3.6. Saudi Arabia Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.4. UAE
                            7.6.4.1. Key Country Dynamics
                            7.6.4.2. Competitive Scenario
                            7.6.4.3. Prevalence Insights
                            7.6.4.4. Regulatory Framework
                            7.6.4.5. Reimbursement Structure
                            7.6.4.6. UAE Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.5. Kuwait
                            7.6.5.1. Key Country Dynamics
                            7.6.5.2. Competitive Scenario
                            7.6.5.3. Prevalence Insights
                            7.6.5.4. Regulatory Framework
                            7.6.5.5. Reimbursement Structure
                            7.6.5.6. Kuwait Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company Categorization
                    8.2. Company Market Share Analysis, 2023
                    8.3. Strategy Mapping
                    8.4. Company Profiles/Listing
                        8.4.1. Lonza
                            8.4.1.1. Overview
                            8.4.1.2. Financial Performance
                            8.4.1.3. Product Benchmarking
                            8.4.1.4. Strategic Initiatives
                        8.4.2. FUJIFILM Diosynth Biotechnologies
                            8.4.2.1. Overview
                            8.4.2.2. Financial Performance
                            8.4.2.3. Product Benchmarking
                            8.4.2.4. Strategic Initiatives
                        8.4.3. Ajinomoto Co., Inc.
                            8.4.3.1. Overview
                            8.4.3.2. Financial Performance
                            8.4.3.3. Product Benchmarking
                            8.4.3.4. Strategic Initiatives
                        8.4.4. Merck KGaA
                            8.4.4.1. Overview
                            8.4.4.2. Financial Performance
                            8.4.4.3. Product Benchmarking
                            8.4.4.4. Strategic Initiatives
                        8.4.5. IDT Biologika GmbH
                            8.4.5.1. Overview
                            8.4.5.2. Financial Performance
                            8.4.5.3. Product Benchmarking
                            8.4.5.4. Strategic Initiatives
                        8.4.6. Curia Global, Inc.
                            8.4.6.1. Overview
                            8.4.6.2. Financial Performance
                            8.4.6.3. Product Benchmarking
                            8.4.6.4. Strategic Initiatives
                        8.4.7. ICON plc.
                            8.4.7.1. Overview
                            8.4.7.2. Financial Performance
                            8.4.7.3. Product Benchmarking
                            8.4.7.4. Strategic Initiatives
                        8.4.8. Cytovance Biologics (Hepalink)
                            8.4.8.1. Overview
                            8.4.8.2. Financial Performance
                            8.4.8.3. Product Benchmarking
                            8.4.8.4. Strategic Initiatives
                        8.4.9. Syngene International Limited
                            8.4.9.1. Overview
                            8.4.9.2. Financial Performance
                            8.4.9.3. Product Benchmarking
                            8.4.9.4. Strategic Initiatives
                        8.4.10. Catalent, Inc
                            8.4.10.1. Overview
                            8.4.10.2. Financial Performance
                            8.4.10.3. Product Benchmarking
                            8.4.10.4. Strategic Initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 4. Global vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 5. Global vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 6. Global vaccine contract manufacturing market, by region, 2018 - 2030 (USD Million)
Table 7. North America vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 8. North America vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 9. North America vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 10. North America vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 11. U.S. vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 12. U.S. vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 13. U.S. vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 14. Canada vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 15. Canada vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 16. Canada vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 17. Europe vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 18. Europe vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 19. Europe vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 20. Europe vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 21. Germany vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 22. Germany vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 23. Germany vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 24. UK vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 25. UK vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 26. UK vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 27. France vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 28. France vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 29. France vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 30. Italy vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 31. Italy vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 32. Italy vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 33. Spain vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 34. Spain vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 35. Spain vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 36. Denmark vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 37. Denmark vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 38. Denmark vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 39. Sweden vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 40. Sweden vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 41. Sweden vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 42. Norway vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 43. Norway vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 44. Norway vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 45. Asia Pacific vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 46. Asia Pacific vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 47. Asia Pacific vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 48. Asia Pacific vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 49. China vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 50. China vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 51. China vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 52. Japan vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 53. Japan vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 54. Japan vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 55. India vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 56. India vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 57. India vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 58. South Korea vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 59. South Korea vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 60. South Korea vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 61. Australia vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 62. Australia vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 63. Australia vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 64. Thailandvaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 65. Thailandvaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 66. Thailandvaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 67. Latin America vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 68. Latin America vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 69. Latin America vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 70. Latin America vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 71. Brazil vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 72. Brazil vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 73. Brazil vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 74. Mexico vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 75. Mexico vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 76. Mexico vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 77. Argentina vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 78. Argentina vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 79. Argentina vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 84. South Africa vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 85. South Africa vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 86. South Africa vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 90. UAE vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 91. UAE vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 92. UAE vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 93. Kuwait vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 94. Kuwait vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 95. Kuwait vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Vaccine Contract Manufacturing Market, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 Global Vaccine Contract Manufacturing Market, for Attenuated Vaccine, 2018 - 2030 (USD Million)
Fig. 16 Global Vaccine Contract Manufacturing Market, for Inactivated Vaccine, 2018 - 2030 (USD Million)
Fig. 17 Global Vaccine Contract Manufacturing Market, for Subunit vaccines, 2018 - 2030 (USD Million)
Fig. 18 Global Vaccine Contract Manufacturing Market, for Toxoid Vaccines, 2018 - 2030 (USD Million)
Fig. 19 Global Vaccine Contract Manufacturing Market, for DNA Vaccines, 2018 - 2030 (USD Million)
Fig. 20 Global Vaccine Contract Manufacturing Market, for Downstream, 2018 - 2030 (USD Million)
Fig. 21 Global Vaccine Contract Manufacturing Market, for Fill & Finish Operations, 2018 - 2030 (USD Million)
Fig. 22 Global Vaccine Contract Manufacturing Market, for Analytical & QC studies, 2018 - 2030 (USD Million)
Fig. 23 Global Vaccine Contract Manufacturing Market, for Packaging, 2018 - 2030 (USD Million)
Fig. 24 Global Vaccine Contract Manufacturing Market, for Upstream, 2018 - 2030 (USD Million)
Fig. 25 Global Vaccine Contract Manufacturing Market, for Mammalian Expression Systems, 2018 - 2030 (USD Million)
Fig. 26 Global Vaccine Contract Manufacturing Market, for Bacterial Expression Systems, 2018 - 2030 (USD Million)
Fig. 27 Global Vaccine Contract Manufacturing Market, for Yeast Expression Systems, 2018 - 2030 (USD Million)
Fig. 28 Global Vaccine Contract Manufacturing Market, for Baculovirus/Insect Expression Systems, 2018 - 2030 (USD Million)
Fig. 29 Global Vaccine Contract Manufacturing Market, for Others, 2018 - 2030 (USD Million)
Fig. 30 Global Vaccine Contract Manufacturing Market, for Human Use, 2018 - 2030 (USD Million)
Fig. 31 Global Vaccine Contract Manufacturing Market, for Veterinary, 2018 - 2030 (USD Million)
Fig. 32 Regional Outlook, 2021 & 2030
Fig. 33 North America Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 34 U.S. Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 35 Canada Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 36 Europe Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 37 Germany Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 38 UK Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 39 France Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 40 Italy Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 41 Spain Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 42 Denmark Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 43 Sweden Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 44 Norway Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 46 Japan Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 47 China Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 48 India Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 49 Australia Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 50 South Korea Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 51 Thailand Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 52 Latin America Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 53 Brazil Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 54 Mexico Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 55 Argentina Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 57 South Africa Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 59 UAE Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 60 Kuwait Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)